Up and Out - Tips on navigating life science relocation (pt2)

Add this event to your calendar:
27/06/2018 10:30 27/06/2018 13:15 America/Los_Angeles Up and Out - Tips on navigating life science relocation (pt2) Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY

Up and Out - Tips on navigating life science relocation (pt2)

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA

June 27, 2018 from 10:30 AM to 13:15 PM (PST)

$10 - $35

Program Overview:
Your innovation is thriving; your company is growing; it is never too early to plan your move up and out. There is a lot to know about building and moving to a new space, but where do you start?

The workplace is changing, a high-performance workplace helps life sciences companies innovate and unlock their potential. However, real estate and regulations can be a frustrating world to navigate. But, fear not!

This workshop, specifically tailored companies on the move. Representatives from recent JLABS relocation, experienced leaders, government and industry professionals will teach you how to successfully prepare for your company's big move and help you avoid the pitfalls that can slow you down.

Topics to be covered:

  • Relocation do's and don'ts
  • What is important when finding a new space
    • How long does it take to find and move into a new space?
    • How do I determine what kind of space and amount of space I need?
    • How much does everything cost?
    • How can my space help me recruit and retain top talent?
    • What are the biggest mistakes companies make?
  • City Resources
  • Learn from experience:
  • What you need to know about the relocation process
    • What didn't you expect?
    • What was different?
    • What were the hardest steps?
  • Relocation Schedules
    • Keep an eye on your time line
  • Budgets
    • What did you prepare for?
    • Unexpected costs?
    • Higher than expected costs?
  • Lease Term Obligations
    • What were the strange lease terms?
  • Market Availability
  • Rents
  • Vacancies

This workshop will include real life example of successful and unsuccessful moves.

Event Partner:

Alex Greenwood | Director,Economic and Community Development, City of South San Francisco read bio»
Allison Hoffmann | Advisor, T3 Advisors read bio»
Kinkead Reiling | CEO & Founder, Bonneville Labs read bio»
Andrew Zink | Senior Principal, T3 Advisors read bio»

Colleen Cutcliffe | Chief Executive Officer and Co-Founder, Whole Biome read bio»
Tom Ruginis | CFO & Operations Advisor, Perlara PBC read bio»
[Emcee] Neema Saless | Operations Manager, JLABS @ SSF read bio»
[Moderator] Jim Viola | Innovation Activation Manager, Johnson & Johnson Innovation, JLABS read bio»


8:30 AM | Registration, Breakfast and Networking
9:00 AM | Community engagement - City of South San Francisco
9:15 AM | Presentation - T3 Advisors
9:35 AM | Bonneville Labs
9:45 AM | JLABS Company Panel Discussion
10:30 AM | Q&A - (All Speakers)
10:45 AM | Networking
11:15 AM | Program Close

329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Presenter Biographies

Alex Greenwood | Director, Economic and Community Development, City of South San Francisco
Alex Greenwood is Director of Community & Economic Development for the City of South San Francisco. His department handles planning, building, housing and economic development for South San Francisco – which is the largest biotechnology cluster in the world. His current projects include: 7.2 million sq. ft. of new biotech development, more than 3,000 of new affordable and market-rate housing, redevelopment of Downtown, and several major mixed-use transit-oriented developments.

Allison Hoffmann | Advisor, T3 Advisors
As an advisor in T3’s West Coast office on the Life Sciences team, I bring my passion for the life sciences industry into everything I do for our clients. I have a true dedication to working with cutting-edge life science companies and ensuring that every inch of their real estate and lab needs are met. As the healthcare landscape continues to evolve, so will our innovative real estate solutions for our clients.

Kinkead Reiling| CEO & Founder, Bonneville Labs
Kinkead Reiling, PhD is founder and CEO of Bonneville Labs, which provided lab space and operations for biotechnology companies. From 2012 to 2016, Dr Reiling advised multiple biotechnology companies and invested in and developed real estate. From 2003 to 2011, Dr Reiling co-founded and helped to grow the industrial biology company Amyris producing Biofuels and Bio-Chemicals. Prior to Amyris, he worked as a post-doctoral scholar in the UC Berkley Chemical Engineering Department developing microbial production systems for Anti-Malarial and Anti-Cancer therapeutic compounds. He completed his doctoral studies at UC, San Francisco in BioPhysics and his Master’s degree in Applied Physics from Columbia University.

Andrew Zink | Senior Principal, T3 Advisors
It’s important that we fully understand our clients—what are their business goals? What unique challenges are they facing? As a Senior Principal at T3 Advisors, it’s my mission to consider all aspects of their business before advising them with their facility decisions. Once we have determined their specific needs, we can leverage T3’s resources to create a thoughtful, strategic plan that will fit together with their larger business objectives. Before joining T3, I spent almost a decade working for one of the top five brokerage firms. I worked with local, national, and international companies, representing a variety of businesses and property owners. This experience gives me the insight necessary to guide our clients through any situation.

Colleen Cutcliffe | Chief Executive Officer and Co-founder, Whole Biome
Colleen Cutcliffe is the co-founder and CEO of Whole Biome, an early stage microbiome company. Colleen has over a decade of experience managing and directing fundamental biology research teams in the academic, pharmaceutical and biotech sectors. Prior to starting Whole Biome, Colleen served as the Senior Manager of Biology at Pacific Biosciences, a Scientist at Elan Pharmaceuticals and a Postdoctoral Fellow at Chicago's Children's Memorial Hospital. Colleen received her Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and her B.A. in Biochemistry from Wellesley College.

Tom Ruginis | CFO & Operations Advisor & Perlara PBC
Tom Ruginis is the part-time CFO and an Operations advisor at Perlara PBC. He's been with the company from (almost) day 1 at QB3 helping them move in, and then move out a few years later. He's helped several other biotech startups move out of incubators, grow up, and become real businesses. He spends most of his time in Chicago but loves the Bay area, and also currently runs another company called HappiLabs.

Neema Saless, PhD | Operations Manager, Johnson & Johnson Innovation, JLABS
Neema Saless is the JLABS Operations Manager at JLABS @ SSF and JLABS @ QB3. As Operations Manager for the Bay Area, Neema supports JLABS current resident companies and the now extensive JLABS alumni companies at both locations, in every way possible, to continue their innovative work and success in healthcare. In this role, Neema supports the Licensee companies by ensuring all JLABS provided equipment is maintained and the scientist are trained and in compliance. Neema enables efficient operational work-flows to ensure compliance related to Environmental Health and Safety and Standard Operating Procedures. The support for the JLABS ecosystem does not stop at the science, Neema and the JLABS team help all the companies meet one another and create relationships within J&J and with the JLABS preferred partners.

[Moderator] Jim Viola | Innovation Activation Manager, Johnson & Johnson Innovation, JLABS
Jim is responsible for marketing and events for JLABS @ SSF and JLABS @ QB3 in the Bay Area. His role includes creating and coordinating high-quality, diverse and distinctive programming ranging from one-on-one investor meetings, workshops and large panel discussions to networking and social events. Jim manages JLABS largest global event held each year at the J.P. Morgan Healthcare Conference and is in charge of keeping the content fresh and relevant as the year-round curriculum is designed to assist innovators along the product development continuum. Key to the success of JLABS is establishing relationships with the Bio community.

Prior to Joining Johnson & Johnson, Jim spent two decades in the powersports industry as a successful special-event and marketing professional. He held the post of Marketing Direct, at Ducati North America, Operations Manager at Premier Event and various positions at BMW of North America. After years of working closely with retailers, distributors and manufacturers of high-end European products, Jim has developed a unique insight into special events and understands how to successfully integrate these programs into solid marketing plans.

Jim holds a B.S. Chemistry from Muhlenberg College and earned his M.B.A at Rutgers University. He currently is on the advisory board of CELS, a non-profit organization whose goal is to support Canadian life science companies, and participates in various event committees in the bay area.

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact

Related content